Pharmafile Logo
Pharmafocus logo
Advanced Search

Dillon

Showing 13 posts of 13 posts found.

Soliris image

NICE approves world’s most expensive drug

January 28, 2015
Sales and Marketing Alexion, Dillon, NHS, NICE, aHUS, eculizumab, hst, soliris

The world’s most expensive drug has been approved in final guidance from NICE, making it the first drug to pass …

News

NICE reform put on hold – for now

September 17, 2014
Sales and Marketing Dillon, NHS, NHS England, NICE, market access, vba

The reforming of NICE has been put on hold as the watchdog believes more changes must be wrought to deal …

News
Yervoy image

NICE recommends Yervoy

June 13, 2014
Sales and Marketing BMS, Cancer, Dillon, NHS, NICE, Yervoy, melanoma

Bristol-Myers Squibb has received a lift from the UK’s drugs watchdog, which has recommended its vaccine Yervoy as a first-line …

News
Haslam image

David Haslam: NICE, drug pricing and ethics

June 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chairman, Dillon, NHS, NICE, adams, has lam

Since 2010, I have spent a great deal of time of writing about NICE, covering nearly all of all its …

Feature
NICE image

NICE launches VBA consultation

March 27, 2014
Sales and Marketing Dillon, England, NHS, NICE, VBP, catchpole, pars, vba

NICE has today launched its consultation into how value-based assessment of drugs will work in practice, which will run for …

News

NICE: new system will allow more drugs on NHS

February 17, 2014
Sales and Marketing DH, Dillon, DoH, NHS, NICE, QALY

NICE has said that it will be able to approve more medicines under a new drug pricing policy, but warns …

News
doh image

NICE rejects ‘benefit’ test

January 28, 2014
Sales and Marketing Dillon, EMIG, NHS, NICE, benefits

NICE has refused to include a ‘wider societal benefit’ test into its deliberations about which drugs should be available on …

News
NICE image

NICE: Daily Mail ‘misled’ readers

January 13, 2014
Sales and Marketing Dillon, NHS, NICE, mail

UK drugs watchdog NICE has hit back at an article in the Daily Mail headlined “Champagne perks of NHS drug …

News
NICE image

NICE tells pharma: don’t blame us for rejections

November 18, 2013
Sales and Marketing Dillon, NHS, NICE, VBP

The head of NICE has publicly defended his agency against more pharma criticism but admits that it can make changes …

News
Lucentis image

NICE ‘yes’ to Lucentis – with price cut

October 25, 2013
Sales and Marketing Dillon, Lucentis, NICE, Novartis

A price cut is the deal-breaking condition attached to NICE’s final draft guidance recommending Lucentis as an option for patients …

News
NICE image

NICE queries pharma R&D costs

September 5, 2013
Research and Development, Sales and Marketing Dillon, NICE, Pfizer, R&D

NICE has questioned whether pharma really spends as much as it says it does on bringing new treatments to market …

News
Zelboraf image

Roche’s Zelboraf rejected by NICE

June 15, 2012
Sales and Marketing Cancer, Dillon, NICE, Roche, Zelboraf, melanoma

NICE is not recommending Roche’s targeted melanoma pill Zelboraf because of its high cost and uncertainties over its survival benefit. …

News
NICE image

NICE comes out fighting against appraisal delays story

May 17, 2012
Sales and Marketing Daily Mail, Dillon, NHS, NICE, Pfizer, Victrelis

NICE has criticised a report that says the watchdog has taken up to nine years to appraise certain drugs.   The …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025